Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Mira Pharmaceuticals, Inc.
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
October 22, 2026
From
Mira Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
MIRA
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
September 17, 2026
From
Mira Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
MIRA
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
September 01, 2026
From
Mira Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
MIRA
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
August 06, 2026
From
Mira Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
MIRA
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
July 30, 2026
From
Mira Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
MIRA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.